Stimuli-responsive nanoparticle-assisted immunotherapy: a new weapon against solid tumours.


Journal

Journal of materials chemistry. B
ISSN: 2050-7518
Titre abrégé: J Mater Chem B
Pays: England
ID NLM: 101598493

Informations de publication

Date de publication:
04 03 2020
Historique:
pubmed: 19 2 2020
medline: 2 4 2021
entrez: 19 2 2020
Statut: ppublish

Résumé

Although significant improvements in cancer treatment have led to a longer survival period, the death rate of patients with solid tumours has not changed during the last decades. Most researchers are currently concentrating on defining the mechanisms of the different resistance pathways activated by tumour cells; meanwhile, the role of limited drug distribution within tumours has been neglected. The application of nanotechnology in medicine offers unexplored opportunities for realizing a new generation of anticancer therapies that can overcome the physical hindrances that characterize solid tumours. Indeed, surface-engineered nanoparticles (NPs) (both organic and inorganic) have been used as powerful tools in cancer therapy. Particularly, Au NPs have been utilized to develop a new drug-free treatment, photo-thermal therapy (PTT), due to their stimuli-responsive properties. PTT combined with immunotherapy represents a major breakthrough in the fight against malignant solid tumours. In this review, we provide a complete overview of the synergistic approaches based on PTT and immunotherapy, considering the selection, design, and functionalization of the NPs and their thermo-optical properties, moving to in vivo studies and finally to clinical trial applications in patients suffering from solid tumours.

Identifiants

pubmed: 32067013
doi: 10.1039/c9tb02246e
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1823-1840

Auteurs

Biagio De Angelis (B)

Department of Onco-Haematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Nicoletta Depalo (N)

CNR-IPCF, National Research Council of Italy, Institute for Physical and Chemical Processes-Bari Division, Via Orabona 4, I-70126 Bari, Italy.

Francesca Petronella (F)

CNR-IC, National Research Council of Italy, Institute Crystallography, Rome Via Salaria Km 29,300, 00015 Monterotondo - Rome, Italy.

Concetta Quintarelli (C)

Department of Onco-Haematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy and Department of Clinical Medicine and Surgery, Federico II University of Naples, Italy.

M Lucia Curri (ML)

CNR-IPCF, National Research Council of Italy, Institute for Physical and Chemical Processes-Bari Division, Via Orabona 4, I-70126 Bari, Italy and Department of Chemistry, University of Bari "A. Moro", Via Orabona 4, I-70126 Bari, Italy.

Roberto Pani (R)

Center for Biophotonics and Department of Medico-surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100, Latina, Italy. luciano.desio@uniroma1.it.

Antonella Calogero (A)

Center for Biophotonics and Department of Medico-surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100, Latina, Italy. luciano.desio@uniroma1.it.

Franco Locatelli (F)

Department of Onco-Haematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy and Department of Pediatrics, Sapienza, University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.

Luciano De Sio (L)

Center for Biophotonics and Department of Medico-surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100, Latina, Italy. luciano.desio@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH